Instrument Inactif

Communiqués Vical Incorporated Nasdaq

Actions

US9256022032

Recherche biotechnologique et médicale

Communiqués

25/02/25	Fresh Tracks Therapeutics Announces Dissolution, Initial Cash Distribution and Termination of Trading on the OTC Pink Market	PR
29/01/25	Fresh Tracks Therapeutics Announces Appointment of Custodian and Planned Distribution	AQ
27/01/25	/C O R R E C T I O N -- Fresh Tracks Therapeutics, Inc./	PR
06/12/24	Fresh Tracks Therapeutics Announces Hearing Date and Notice of Proposed Consent Judgement Regarding Dissolution of Company	PR
17/06/24	Fresh Tracks Therapeutics Announces Delaware Petition Filed Seeking Appointment of Custodian for Eventual Dissolution of Company	AQ
07/03/24	Fresh Tracks Therapeutics : Termination of Material Agreement - Form 8-K	PU
14/02/24	Fresh Tracks Therapeutics Urges Stockholders to Vote at the Upcoming Special Meeting on February 15th	AQ
27/12/23	Fresh Tracks Therapeutics Announces Plan to Hold New Special Meeting of Stockholders on February 15th	AQ
19/12/23	Fresh Tracks Therapeutics Announces Listing on OTC Pink Market	AQ
18/12/23	Fresh Tracks Therapeutics Announces its Common Stock will be Suspended from Trading on Nasdaq at Open of Business on December 19th	AQ
15/12/23	Fresh Tracks Therapeutics : Termination of Material Agreement - Form 8-K	PU
15/12/23	Fresh Tracks Therapeutics Announces Third Adjournment of Special Meeting of Stockholders	AQ
04/12/23	Fresh Tracks Therapeutics Announces Second Adjournment of Special Meeting of Stockholders	AQ
01/12/23	Fresh Tracks Therapeutics Announces Second Adjournment of Special Meeting of Stockholders	AQ
20/11/23	Fresh Tracks Therapeutics Announces Adjournment of Special Meeting of Stockholders	AQ
17/11/23	Fresh Tracks Therapeutics Announces Adjournment of Special Meeting of Stockholders	AQ
13/11/23	Fresh Tracks Therapeutics: Q3 Earnings Snapshot	AQ
13/11/23	Fresh Tracks Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update	AQ
19/09/23	Fresh Tracks Therapeutics Announces Board Approval of Plan of Liquidation and Dissolution	AQ
14/08/23	Fresh Tracks Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update	AQ
11/08/23	Fresh Tracks Therapeutics: Q2 Earnings Snapshot	AQ
11/08/23	Fresh Tracks Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update	AQ
24/07/23	Fresh Tracks Announces $8.25 Million Buyout of Its Right to Receive Future Sofpironium Bromide Payments from Botanix	AQ
10/05/23	Fresh Tracks Therapeutics: Q1 Earnings Snapshot	AQ
10/05/23	Fresh Tracks Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update	AQ